Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Fingerprint Dive into the research topics of 'Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine'. Together they form a unique fingerprint.

Medicine & Life Sciences